Earnings Per Share, Diluted of INTERCEPT PHARMACEUTICALS, INC. from 30 Jun 2013 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 30 Jun 2013 to 30 Sep 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Earnings Per Share, Diluted for the quarter ending 30 Sep 2023 was -0.07, a 101% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. Earnings Per Share, Diluted for the twelve months ending 30 Sep 2023 was -1, a 126% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2022 was 6.56.
  • INTERCEPT PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2021 was -2.87, a 66% increase from 2020.
  • INTERCEPT PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2020 was -8.34, a 23% increase from 2019.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 -1 -0.07 -7.87 -101% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 6 -0.14 +0.11 +44% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 6 -0.77 -0.19 -33% 01 Jan 2023 31 Mar 2023 10-Q 27 Apr 2023 2023 Q1
Q4 2022 6 -0.5 +0.73 +59% 01 Oct 2022 31 Dec 2022 10-K 02 Mar 2023 2022 FY
Q3 2022 6 7.8 +7.91 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 -2 -0.25 +0.08 +24% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 -2 -0.58 +0.64 +52% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q4 2021 -3 -1.23 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 -0.11 +1.9 +95% 01 Jul 2021 30 Sep 2021 10-K 02 Mar 2023 2022 FY
Q2 2021 -0.33 01 Apr 2021 30 Jun 2021 10-K 02 Mar 2023 2022 FY
Q1 2021 -1.22 01 Jan 2021 31 Mar 2021 10-K 02 Mar 2023 2022 FY
Q3 2020 -2.01 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2015 -1.99 -3.5 -232% 01 Apr 2015 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q4 2014 -14 -1.63 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 -1.69 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016 2015 FY
Q2 2014 1.51 +2.3 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016 2015 FY
Q1 2014 -12.61 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016 2015 FY
Q2 2013 -0.79 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014 2014 Q2

INTERCEPT PHARMACEUTICALS, INC. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 6.56 +9.43 01 Jan 2022 31 Dec 2022 10-K 02 Mar 2023 2022 FY
2021 -2.87 +5.47 +66% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 -8.34 +2.55 +23% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023 2022 FY
2019 -10.89 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.